Patents by Inventor Kook-Jin Lim
Kook-Jin Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12146879Abstract: An apparatus for inspecting an antibiotic and a method for determining antibiotic sensitivity using the same is provided. The antibiotic susceptibility inspection time which has conventionally taken longer than 24 hours is shortened to about 2 hours or less, the efficacy of the target substance is monitored in real time, the identification of the microorganism, the kind of the antibiotic capable of treating the microorganism, and the minimum dosage thereof are quickly confirmed. Microbial infections requiring prompt diagnosis and treatment can be effectively treated.Type: GrantFiled: October 12, 2020Date of Patent: November 19, 2024Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITYInventors: Kyung Hwa Yoo, Nal Ae Han, Bong Jun Kim, Sun Mi Lee, Kook Jin Lim, Jeseung Oh
-
Publication number: 20240043903Abstract: The present invention relates to a biosensor for inspecting the susceptibility of a microorganism to an antibiotic, a fabrication method therefor, and a method for inspecting the susceptibility of a microorganism to an antibiotic by using same, wherein the biosensor comprises: a substrate including polyethylene terephthalate; and a sensor part formed on one surface or both surfaces of the substrate and comprising an electrode inclusive of a first electrode and a second electrode which interdigitate with each other.Type: ApplicationFiled: December 17, 2021Publication date: February 8, 2024Applicant: PROTEOMETECH INC.Inventors: Kook Jin LIM, Han Seung JOO, Je Seung OH, Chang Su LIM
-
Publication number: 20220146509Abstract: The present invention relates to a chromatography strip for diagnosing pregnancy having multiple test lines, a pregnancy diagnosis kit having the chromatography strip, and a method for diagnosing pregnancy using the same. The present invention overcomes the problem of false negatives due to hCG variants such that pregnancy can be determined more accurately and conveniently by the naked eye. Furthermore, there is an effect of improving the concentration measurement range of hCG or a variant thereof by using a chromatography strip for diagnosing pregnancy which is constituted by multiple test lines and control lines.Type: ApplicationFiled: July 10, 2019Publication date: May 12, 2022Applicant: ProteomeTech Inc.Inventors: Kook Jin LIM, Tae Hyong KIM, Dong Suk PARK, Dong Seob CHOI, Mi Jeoung KIM, Young Woo PARK
-
Publication number: 20210164974Abstract: The present invention relates to: a chromatographic strip comprising a plurality of test lines for a competitive assay; a diagnostic kit comprising the chromatographic strip; and a method for qualitatively or quantitatively analyzing a target material within a specimen by using the same. By using the chromatographic strip of the present invention, qualitative analysis and highly reliable quantitative analysis can be rapidly and conveniently carried out with the naked eyes or a sensor even for a target material, which has one ligand binding position or is small. Furthermore, the present invention has an effect of improving the concentration measurement range of an analyte by the mutual supplementation of test lines and control lines.Type: ApplicationFiled: September 7, 2018Publication date: June 3, 2021Applicant: ProteomeTech Inc.Inventors: Kook Jin LIM, Tae Hyoung KIM, Dong Suk PARK, Seok Kyo SHIN, Mi Jeoung KIM
-
Publication number: 20210140963Abstract: An apparatus for inspecting an antibiotic and a method for determining antibiotic sensitivity using the same is provided. The antibiotic susceptibility inspection time which has conventionally taken longer than 24 hours is shortened to about 2 hours or less, the efficacy of the target substance is monitored in real time, the identification of the microorganism, the kind of the antibiotic capable of treating the microorganism, and the minimum dosage thereof are quickly confirmed. Microbial infections requiring prompt diagnosis and treatment can be effectively treated.Type: ApplicationFiled: October 12, 2020Publication date: May 13, 2021Applicants: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY, PROTEOMETECH INC.Inventors: Kyung Hwa YOO, Nal Ae HAN, Bong Jun KIM, Sun Mi LEE, Kook Jin LIM, Jeseung OH
-
Patent number: 10900963Abstract: The present invention is related to a parallel line biochip for multiplex diagnosis. The parallel line biochip for multiplex diagnosis includes a plurality of line strips disposed in parallel, and a well configured to immobilize the line strips. Since the parallel line biochip for multiplex diagnosis can be used to connect two or more line strips in parallel, the parallel line biochip for multiplex diagnosis has an effect of measuring various materials present in a biological test sample at the same time.Type: GrantFiled: January 15, 2014Date of Patent: January 26, 2021Inventors: Kook Jin Lim, Dong Seob Choi, Bum Joon Kim, Mi Jung Kim, Myung Sook Chung, Hye Jung Lee
-
Patent number: 10809263Abstract: Provided are an autoantibody specifically binding to an exosomal protein EIF3A (Eukaryotic translation initiation factor 3 subunit A) or a fragment including an antigen-binding site (paratope) thereof, a hybridoma cell line producing the autoantibody, a polypeptide having an amino acid sequence of an antigenic determinant (epitope) specifically binding to the autoantibody, a composition for diagnosing liver cancer including an agent measuring an expression level of the autoantibody or the fragment including the antigen-binding site thereof, a kit for diagnosing liver cancer including the composition, and a method of providing information for diagnosis of liver cancer by using the composition. Further, provided is a method of screening for a therapeutic agent for liver cancer by using an expression level of the autoantibody.Type: GrantFiled: July 8, 2016Date of Patent: October 20, 2020Assignees: PROTEOMETECH INC., KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGYInventors: Eun Wie Cho, Chang Kyu Heo, Hai Min Hwang, Jeong Heon Ko, Kook Jin Lim, Hye Jung Lee
-
Publication number: 20190204324Abstract: Provided are an autoantibody specifically binding to an exosomal protein EIF3A (Eukaryotic translation initiation factor 3 subunit A) or a fragment including an antigen-binding site (paratope) thereof, a hybridoma cell line producing the autoantibody, a polypeptide having an amino acid sequence of an antigenic determinant (epitope) specifically binding to the autoantibody, a composition for diagnosing liver cancer including an agent measuring an expression level of the autoantibody or the fragment including the antigen-binding site thereof, a kit for diagnosing liver cancer including the composition, and a method of providing information for diagnosis of liver cancer by using the composition. Further, provided is a method of screening for a therapeutic agent for liver cancer by using an expression level of the autoantibody.Type: ApplicationFiled: July 8, 2016Publication date: July 4, 2019Applicants: Korea Research Institute of Bioscience and Biotechnology, ProteomeTech Inc.Inventors: Eun Wie Cho, Chang Kyu Heo, Hai Min Hwang, Jeong Heon Ko, Kook Jin Lim, Hye Jung Lee
-
Patent number: 10041952Abstract: Provided is a composition for detecting a protein, containing a tyrosine oxide-coupled biomaterial. Various diseases may be easily and rapidly diagnosed by easily detecting the composition containing a tyrosine oxide-coupled biomaterial according to the present invention, by identifying a color of the protein bound with a tyrosine oxide-coupled biomaterial prepared by binding tyrosine oxide, which is a natural pigment present in a living body, with the biomaterial. Accordingly, the composition of the present invention may be used to easily and rapidly diagnose various diseases in real time in an operating room, and may usefully replace conventional histological analysis without a secondary antibody reaction and a final operation of color expression.Type: GrantFiled: January 20, 2012Date of Patent: August 7, 2018Assignee: PROTEOMETECH INC.Inventors: Kook Jin Lim, Jin Ik Lim, Bum Joon Kim, Kyung Hwa Yoo, Soo Jung Park
-
Publication number: 20180045725Abstract: An apparatus for inspecting an antibiotic and a method for determining antibiotic sensitivity using the same is provided. The antibiotic susceptibility inspection time which has conventionally taken longer than 24 hours is shortened to about 2 hours or less, the efficacy of the target substance is monitored in real time, the identification of the microorganism, the kind of the antibiotic capable of treating the microorganism, and the minimum dosage thereof are quickly confirmed. Microbial infections requiring prompt diagnosis and treatment can be effectively treated.Type: ApplicationFiled: August 14, 2017Publication date: February 15, 2018Applicants: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY, PROTEOMETECH INC.Inventors: Kyung Hwa YOO, Nal Ae HAN, Bong Jun KIM, Sun Mi LEE, Kook Jin LIM, Jeseung OH
-
Publication number: 20150362487Abstract: The present invention is related to a parallel line biochip for multiplex diagnosis. The parallel line biochip for multiplex diagnosis includes a plurality of line strips disposed in parallel, and a well configured to immobilize the line strips. Since the parallel line biochip for multiplex diagnosis can be used to connect two or more line strips in parallel, the parallel line biochip for multiplex diagnosis has an effect of measuring various materials present in a biological test sample at the same time.Type: ApplicationFiled: January 15, 2014Publication date: December 17, 2015Inventors: Kook Jin Lim, Dong Seob Choi, Bum Joon Kim, Mi Jung Kim, Myung Sook Chung, Hye Jung Lee
-
Publication number: 20130302911Abstract: Provided is a composition for detecting a protein, containing a tyrosine oxide-coupled biomaterial. Various diseases may be easily and rapidly diagnosed by easily detecting the composition containing a tyrosine oxide-coupled biomaterial according to the present invention, by identifying a color of the protein bound with a tyrosine oxide-coupled biomaterial prepared by binding tyrosine oxide, which is a natural pigment present in a living body, with the biomaterial. Accordingly, the composition of the present invention may be used to easily and rapidly diagnose various diseases in real time in an operating room, and may usefully replace conventional histological analysis without a secondary antibody reaction and a final operation of color expression.Type: ApplicationFiled: January 20, 2012Publication date: November 14, 2013Applicant: PROTEOME TECH. CO., LTD.Inventors: Kook Jin Lim, Jin Ik Lim, Bum Joon Kim, Kyung Hwa Yoo, Soo Jung Park
-
Publication number: 20090117597Abstract: The present invention relates to a method for measuring heptoglobin level in blood serum by using antibodies for ? and ? subunits of heptoglobin, and a kit for immunodetection of heptoglobin which comprises the antibodies for ? and ? subunits of heptoglobin for measuring heptoglobin level in blood serum. A method for measuring heptoglobin level in blood serum of the present invention comprises the steps of: reacting blood serum of a subject with an antibody (?h antibody) which binds specifically to ? subunit of a dimeric heptoglobin and an antibody (?h antibody) which binds specifically to ? subunit of a dimeric heptoglobin; and, measuring level of proteins which react with the ?h antibody and ?h antibody in blood serum and have a molecular weight of more than 100 kDa.Type: ApplicationFiled: November 16, 2005Publication date: May 7, 2009Inventors: Yu-Sam Kim, Kook-Jin Lim
-
Publication number: 20040132117Abstract: The present invention relates to an immunoassay and diagnostic reagent for malaria by using antigens of malarial Protozoa. More preferably, the present invention relates to an immunoassay and diagnostic reagent for malaria which detect malaria-specific antibodies in blood by using Merozoite Surface Protein of Plasmodium vivax. The immunoassay and diagnostic reagent detecting malaria-specific antibodies in blood according to the present invention have high specificity and sensitivity and are useful in diagnosing a type of malaria where latent period is long and number of Protozoa in blood if few. Also, the present invention relates to a preparation method of the surface protein of malarial Protozoa using yeast or E. Coli. Preferably, the present invention provides an expression vector comprising genes of Merozoite Surface Protein of Plasmodium Vivax and histidine residues, as well as transformants transformed with the expression vector.Type: ApplicationFiled: August 7, 2002Publication date: July 8, 2004Inventors: Kook-Jin Lim, Mi-Jin Shon, Seung-Bum Yoo, Sang-Ik Lee, Jae-Hoon Oh, Seung-Won Lee, Hyung-Cheol Kim
-
Patent number: 6538126Abstract: The present invention provides polynucleotides derived from cDNA of novel type of hepatitis C virus named Korean type hepatitis C virus (KHCV), polypeptides encoded therein, and antibodies directed against the polypeptides; and also provide diagnostics and vaccines employing any of the above materials as active ingredient(s).Type: GrantFiled: April 20, 1994Date of Patent: March 25, 2003Assignee: Lucky LimitedInventors: Joong Myung Cho, Yong Beom Lee, Young Woo Park, Kook Jin Lim, Deog Young Choi, Hong Seob So, Chun Hyung Kim, Sung Taek Kim, Jae Young Yang
-
Publication number: 20030032008Abstract: The present invention relates to diagnostic reagents for antibody against hepatitis B surface antigen and for antibody against hepatitis B virus using a sandwich immunoassay as a quantitative or qualitative analysis method for antibody against hepatitis B surface antigen and for antibody against hepatitis B virus, characterized in that each diagnostic reagent comprises a pair of hepatitis B surface antigens which are different each other and composed of primary antigen immobilized on a solid support and secondary antigen conjugated to a marker. Also, the present invention relates to preparation methods thereof. Further, the present invention relates to diagnostic methods for antibody against hepatitis B surface antigen and for antibody against hepatitis B virus.Type: ApplicationFiled: July 25, 2002Publication date: February 13, 2003Inventors: Kook-Jin Lim, Jae-Hoon Oh, Mi-Jin Shon, Seung-Bum Yoo, Sang-Ik Lee
-
Patent number: 6362320Abstract: A process for purifying hepatitis B viral surface antigen comprising the preS2 peptide from the cells of a recombinant organism is carried out by a sequence of steps which includes the step of disrupting the cells using a buffer containing a chaotropic salt to obtain a cell homogenate and the step of alkalifying the cell homogenate to a pH ranging from 11.0 to 13.5.Type: GrantFiled: November 2, 1999Date of Patent: March 26, 2002Assignee: LG Chemical LimitedInventors: Soon-Jae Park, Young-Mee Lee, Kyung-Hee Yoon, Kook-Jin Lim, Young-Sun Kwon